Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
61°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
March 24, 2024
Tags
Business
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Two fresh ways to play the weight loss and megacap tech hype
March 23, 2024
Tags
Exchange/traded funds
stocks
Weight loss diets
From
CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
March 23, 2024
Tags
Eli Lilly and Co
Business
Biotech and Pharmaceuticals
From
CNBC.com News
Cramer's Lighting Round: Arm is a buy
March 22, 2024
Tags
Unity Software Inc
SoundHound AI Inc
Business News
From
CNBC.com News
Medicare can now cover certain weight loss drugs in a big step for patients
March 21, 2024
Tags
Social issues
Biotechnology
Health care industry
From
CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
March 19, 2024
Tags
Akero Therapeutics Inc
Biotech and Pharmaceuticals
Science
From
CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
March 16, 2024
Tags
Weight management
Breaking news
Health & Science
From
CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
March 14, 2024
Tags
Eli Lilly and Co
Business
Biotech and Pharmaceuticals
From
CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
March 14, 2024
Tags
Health & Science
Drugs
Novo Nordisk A/S
From
CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
March 13, 2024
Tags
Investing
U/S/ Markets
Health & Science
From
CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
March 13, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Business
From
CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
March 08, 2024
Tags
Investment strategy
U/S/ Markets
Investing
From
CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
March 08, 2024
Tags
Breaking News: Business
Social issues
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
March 08, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Business
From
CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
March 08, 2024
Tags
Pharmaceuticals
Tesla Inc
Europe News
From
CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
March 07, 2024
Tags
Novo Nordisk A/S
Europe Markets
Markets
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
March 05, 2024
Tags
Health care industry
Biotechnology
Pharmaceuticals
From
CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
March 04, 2024
Tags
Eli Lilly and Co
Business
Novo Nordisk A/S
From
CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
March 03, 2024
Tags
Eli Lilly and Co
Business
Novo Nordisk A/S
From
CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
March 01, 2024
Tags
FactSet Research Systems Inc
Politics
Markets
From
CNBC.com News
5 things to know before the stock market opens Thursday
February 29, 2024
Tags
Economy
Technology
Novo Nordisk A/S
From
CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
February 29, 2024
Tags
Market Outlook
Alphabet Inc
Reliance Steel & Aluminum Co
From
CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
February 28, 2024
Tags
Market Outlook
Paramount Global
Reliance Steel & Aluminum Co
From
CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
February 28, 2024
Tags
Eli Lilly and Co
Diets and dieting
Novo Nordisk A/S
From
CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
February 28, 2024
Tickers
CATS
DOGS
PETS
Tags
Eli Lilly and Co
Health Insurance
Health insurance
From
CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
February 27, 2024
Tags
UnitedHealth Group Inc
Health care industry
Healthy Returns
From
CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
Tags
L'Oreal SA
Nestle SA
ASML Holding NV
From
CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
February 26, 2024
Tags
Pharmaceuticals
Europe News
Novo Nordisk A/S
From
CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
February 16, 2024
Tags
Health Insurance
Health insurance
Eli Lilly and Co
From
CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
February 10, 2024
Tags
Health care industry
Biotechnology
Amgen Inc
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.